Point-of-Care Market Research Reports & Industry Analysis
This value added aspect of POC testing will become even more essential as the menu for POC tests expands with the availability of more tests for cancer and cardiovascular diseases. These test results are more complex and need the support of professional guidance.
In the meantime, investments in high technology made during the 1990s will begin to find commercial appeal in the next five years and will spawn a new genre of POC diagnostic tests and devices. These technological advances will interact with a number of enabling healthcare delivery trends to change the face of clinical diagnostics and the economics of healthcare in general.
Industry professionals anticipate that patient self-testing will skyrocket because of rising consumer expectations, technological innovations, and the surge of consumer activism in healthcare. Further pharmacies, retail outlets and the physician office are establishing their position for patient wellness screening. As the cost of POC devices becomes more affordable and healthcare organizations have constructed data management infrastructures, point-of-care testing has also become an attractive operational and economical alternative to traditional laboratory-based testing in a variety of situations, including physician office testing, home care and in-hospital care.
Point-of-Care Industry Research & Market Reports
-
2024-2029 Mycoplasma Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Mycoplasma tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Papillomavirus Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Papillomavirus tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024-2029 Salmonella Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Salmonella tests performed in the following market segments: Hospitals - Commercial/Private Labs - ... Read More
-
2024-2029 RSV Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Respiratory Syncytial Virus tests performed in the following market segments: Hospitals - ... Read More
-
2024-2029 Syphilis Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Syphilis tests performed in the following market segments: Birth Centers ... Read More
-
2024-2029 Gonorrhea Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Gonorrhea tests performed in the following market segments: Birth Centers - ... Read More
-
2024-2029 Influenza Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Influenza tests performed in the following market segments: Hospitals Commercial/Private Labs ... Read More
-
2024-2029 Malaria Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Malaria tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024-2029 Mononucleosis Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Mononucleosis tests performed in the following market segments: Ambulatory Care Centers - ... Read More
-
2024-2029 Meningitis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Meningitis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Shigella Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Shigella tests performed in the following market segments: Hospitals - Commercial/Private Labs - ... Read More
-
2024-2029 Rubella Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Rubella tests performed in the following market segments: Hospitals - Commercial/Private Labs ... Read More
-
2024-2029 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Chancroid Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chancroid tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024-2029 Chlamydia Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chlamydia tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Coxsackievirus Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Coxsackievirus tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024-2029 Cyclospora Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Cyclospora tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024 United Kingdom In-Vitro Diagnostics (Ivd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Global In-Vitro Diagnostics (Ivd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 China In-Vitro Diagnostics (Ivd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States In-Vitro Diagnostics (Ivd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Japan In-Vitro Diagnostics (Ivd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 China Point-Of-Care (Poc) Testing (Poct) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 United States Point-Of-Care (Poc) Testing (Poct) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 North America Point-Of-Care (Poc) Testing (Poct) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More